510(k) K200215
K200215 is an FDA 510(k) premarket notification submitted by Siemens Healthcare Disgnostics, Inc. for the device "ADVIA Centaur CEA Assay". The FDA issued a decision of Substantially Equivalent on Apr 13, 2020. The device falls under product code DHX (System, Test, Carcinoembryonic Antigen), a Class II device regulated under 21 CFR 866.6010.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Apr 13, 2020
- Date Received
- Jan 28, 2020
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- System, Test, Carcinoembryonic Antigen
- Device Class
- Class II
- Regulation Number
- 866.6010
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for Siemens Healthcare Disgnostics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.